| OAYLX | VIVIX | OAYLX / VIVIX | |
| Total Expense Ratio | 0.87 | 0.04 | 2,175% |
| Annual Report Gross Expense Ratio | 0.87 | 0.04 | 2,175% |
| Fund Existence | 9 years | 27 years | - |
| Gain YTD | 6.241 | 11.991 | 52% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 100000 | 5000000 | 2% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 7.61B | 208B | 4% |
| Annual Yield % from dividends | 0.41 | 2.10 | 19% |
| Returns for 1 year | 3.36 | 6.69 | 50% |
| Returns for 3 years | 58.11 | 33.49 | 174% |
| Returns for 5 years | 95.95 | 66.36 | 145% |
| Returns for 10 years | N/A | 134.98 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| OGMIX | 55.40 | 1.69 | +3.15% |
| Invesco Gold & Special Minerals R6 | |||
| MCYCX | 13.52 | 0.05 | +0.37% |
| NYLI Candriam Emerging Markets Eq Cl C | |||
| RMFFX | 62.99 | 0.14 | +0.22% |
| American Funds American Mutual R5 | |||
| BTIEX | 176.72 | 0.11 | +0.06% |
| DWS Equity 500 Index S | |||
| GSUSX | 58.03 | 0.01 | +0.02% |
| Goldman Sachs US Equity Insights C | |||